AFM
YARW

Anson Funds Management’s Yarrow Bioscience YARW Stock Holding History

Anson Funds Management’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.41K Sell
289
-24,573
-99% -$797K ﹤0.01% 173
2026
Q1 		$743K Sell
24,862
-626
-2% -$18.3K 0.06% 112
2025
Q4 		$739K Buy
+25,488
New +$512K 0.07% 100

Other funds holding YARW

ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Anson Funds Management's YARW Position: Q2 2026 in Review

Anson Funds Management reduced its Yarrow Bioscience (YARW) stake by 99% in Q2 2026, selling an estimated $797K and leaving 289 shares worth $9.41K. The position accounts for ﹤0.01% of the portfolio, ranked #173.

Anson Funds Management first reported a position in YARW in Q4 2025 and has held it in 3 quarters since. The position peaked at $743K in Q1 2026. 40 funds tracked by Wall St. Rank hold YARW as of Q2 2026.

  • Anson Funds Management held 289 shares of Yarrow Bioscience worth $9.41K as of Q2 2026.
  • Anson Funds Management sold 24,573 Yarrow Bioscience shares in Q2 2026, an estimated $797K.
  • Yarrow Bioscience made up ﹤0.01% of Anson Funds Management's portfolio in Q2 2026, its #173 holding.
  • Anson Funds Management first reported a position in Yarrow Bioscience in Q4 2025 and has held it in 3 quarters since.
  • Anson Funds Management's Yarrow Bioscience position peaked at $743K in Q1 2026.
  • 40 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2026.

Based on Anson Funds Management's 13F filing for Q2 2026, filed 13 Aug 2026.